List of Soluprep drug patents
Soluprep is owned by 3M Health Care.
Soluprep contains Chlorhexidine Gluconate; Isopropyl Alcohol.
Soluprep has a total of 1 drug patent out of which 0 drug patents have expired.
Soluprep was authorised for market use on 08 August, 2018.
Soluprep is available in solution;topical dosage forms.
Soluprep can be used as for the preparation of skin prior to surgery; helps reduce bacteria that can potentially cause skin infection.
The generics of Soluprep are possible to be released after 26 July, 2029.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8623935 | 3M HEALTH CARE | Antimicrobial compositions |
Jul, 2029
(6 years from now) | |
Drugs and Companies using CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL ingredient
Market Authorisation Date: 08 August, 2018
Treatment: For the preparation of skin prior to surgery; Helps reduce bacteria that can potentially cause skin infection
Dosage: SOLUTION;TOPICAL
SOLUPREP family patents
3
United States
2
China
2
European Union
1
Japan
1
Brazil
1
Canada
1
Australia
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic